These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22313437)

  • 1. Predicting chronic kidney disease outcomes: are two estimated glomerular filtration rates better than one?
    DeVille J; Smith DH; Johnson ES; Yang X; Petrik AF; Weiss JR; Thorp ML
    Popul Health Manag; 2012 Apr; 15(2):113-8. PubMed ID: 22313437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of renal replacement therapy and mortality using 1 versus 2 estimated glomerular filtration rates.
    Thorp ML; Weinstein J; DeVille J; Johnson ES; Petrik A; Yang X; Smith DH
    Popul Health Manag; 2009 Jun; 12(3):149-55. PubMed ID: 19534579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease.
    Conway B; Webster A; Ramsay G; Morgan N; Neary J; Whitworth C; Harty J
    Nephrol Dial Transplant; 2009 Jun; 24(6):1930-7. PubMed ID: 19181760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of fluid overload with kidney disease progression in advanced CKD: a prospective cohort study.
    Tsai YC; Tsai JC; Chen SC; Chiu YW; Hwang SJ; Hung CC; Chen TH; Kuo MC; Chen HC
    Am J Kidney Dis; 2014 Jan; 63(1):68-75. PubMed ID: 23896483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability in estimated glomerular filtration rate values is a risk factor in chronic kidney disease progression among patients with diabetes.
    Tseng CL; Lafrance JP; Lu SE; Soroka O; Miller DR; Maney M; Pogach LM
    BMC Nephrol; 2015 Mar; 16():34. PubMed ID: 25885708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
    Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
    Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.
    Ryom L; Kirk O; Lundgren JD; Reiss P; Pedersen C; De Wit S; Buzunova S; Gasiorowski J; Gatell JM; Mocroft A;
    HIV Med; 2013 Sep; 14(8):503-8. PubMed ID: 23590641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The practical implications of using standardized estimation equations in calculating the prevalence of chronic kidney disease.
    Quinn MP; Rainey A; Cairns KJ; Marshall AH; Savage G; Kee F; Peter Maxwell A; Reaney E; Fogarty DG
    Nephrol Dial Transplant; 2008 Feb; 23(2):542-8. PubMed ID: 17890743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease.
    Ekart R; Ferjuc A; Furman B; Gerjevič Š; Bevc S; Hojs R
    Ther Apher Dial; 2013 Aug; 17(4):363-7. PubMed ID: 23931872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of urinary sodium excretion and the need for renal replacement therapy in advanced chronic kidney disease: a cohort study.
    Mazarova A; Molnar AO; Akbari A; Sood MM; Hiremath S; Burns KD; Ramsay TO; Mallick R; Knoll GA; Ruzicka M
    BMC Nephrol; 2016 Sep; 17(1):123. PubMed ID: 27596141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis.
    Sato H; Kuroda T; Tanabe N; Ajiro J; Wada Y; Murakami S; Sakatsume M; Nakano M; Gejyo F
    Scand J Rheumatol; 2010; 39(1):33-7. PubMed ID: 20132068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A programme to spread eGFR graph surveillance for the early identification, support and treatment of people with progressive chronic kidney disease (ASSIST-CKD): protocol for the stepped wedge implementation and evaluation of an intervention to reduce late presentation for renal replacement therapy.
    Gallagher H; Methven S; Casula A; Thomas N; Tomson CR; Caskey FJ; Rose T; Walters SJ; Kennedy D; Dawnay A; Cassidy M; Fluck R; Rayner HC; Nation M
    BMC Nephrol; 2017 Apr; 18(1):131. PubMed ID: 28399810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical risk implications of the CKD Epidemiology Collaboration (CKD-EPI) equation compared with the Modification of Diet in Renal Disease (MDRD) Study equation for estimated GFR.
    Matsushita K; Tonelli M; Lloyd A; Levey AS; Coresh J; Hemmelgarn BR;
    Am J Kidney Dis; 2012 Aug; 60(2):241-9. PubMed ID: 22560843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated Glomerular Filtration Rate Within the Normal or Mildly Impaired Range and Incident Cardiovascular Disease.
    Eisen A; Hoshen M; Balicer RD; Reges O; Rabi Y; Leibowitz M; Iakobishvili Z; Hasdai D
    Am J Med; 2015 Sep; 128(9):1015-22.e2. PubMed ID: 25863153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of glomerular filtration rate: does haemoglobin discriminate between ageing and true CKD?
    Ferrari P; Xiao J; Ukich A; Irish A
    Nephrol Dial Transplant; 2009 Jun; 24(6):1828-33. PubMed ID: 19131346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting renal replacement therapy and mortality in CKD.
    Johnson ES; Thorp ML; Yang X; Charansonney OL; Smith DH
    Am J Kidney Dis; 2007 Oct; 50(4):559-65. PubMed ID: 17900455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic creatinine assays allow estimation of glomerular filtration rate in stages 1 and 2 chronic kidney disease using CKD-EPI equation.
    Kuster N; Cristol JP; Cavalier E; Bargnoux AS; Halimi JM; Froissart M; Piéroni L; Delanaye P;
    Clin Chim Acta; 2014 Jan; 428():89-95. PubMed ID: 24220551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does stage III chronic kidney disease always progress to end-stage renal disease? A ten-year follow-up study.
    Baek SD; Baek CH; Kim JS; Kim SM; Kim JH; Kim SB
    Scand J Urol Nephrol; 2012 Jun; 46(3):232-8. PubMed ID: 22545920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality risk stratification in chronic kidney disease: one size for all ages?
    O'Hare AM; Bertenthal D; Covinsky KE; Landefeld CS; Sen S; Mehta K; Steinman MA; Borzecki A; Walter LC
    J Am Soc Nephrol; 2006 Mar; 17(3):846-53. PubMed ID: 16452492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.